Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma
Titel:
Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma
Auteur:
Bechter, Oliver E. Dumez, Herlinde Costermans, Jo Punie, Kevin Hsu, Karl Dedieu, Jean-François Ghuysen, Anne-Frédérique Francesconi, Elisa Sharma, Jyoti Liu, Li Schöffski, Patrick